Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Med Microbiol ; 62(Pt 7): 1092-1093, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23682167

RESUMO

Actinobaculum schaalii is a Gram-positive coccoid rod that causes various infections in humans and is easily overlooked in cultures. A. schaalii has long been thought to be of low prevalence and limited invasive potential, causing benign cystitis in elderly patients with underlying urological conditions. Here, we report the first case of epididymitis caused by this bacterium.


Assuntos
Actinomycetaceae/isolamento & purificação , Infecções por Actinomycetales/microbiologia , Epididimite/microbiologia , Actinomycetaceae/classificação , Actinomycetaceae/efeitos dos fármacos , Infecções por Actinomycetales/tratamento farmacológico , Infecções por Actinomycetales/patologia , Idoso de 80 Anos ou mais , Antibacterianos/uso terapêutico , Farmacorresistência Bacteriana , Epididimite/tratamento farmacológico , Epididimite/patologia , Humanos , Masculino
2.
J Med Eng Technol ; 36(3): 147-55, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22384986

RESUMO

This study provides an update on the technological aspects of the methods for active removal of renal stones. Currently, extracorporeal shock wave lithotripsy (ESWL), ureteroscopy (URS) and percutaneous nephrolithotomy (PCNL) are the available options. Findings are based upon recent literature from the PubMed database and the European Association of Urology (EAU) guidelines. ESWL remains the option of choice for stones with diameter ≤ 20 mm due to its low invasive character, whereas PCNL is the standard for stones with diameter > 20 mm because of its high stone-free rates. Although ESWL treatment has become more patient friendly, its efficacy has not improved. On the other hand, URS has gained renewed interest due to new technological developments and improved treatment methods.


Assuntos
Cálculos Renais/terapia , Humanos , Litotripsia , Nefrostomia Percutânea , Ureteroscopia
3.
ISRN Surg ; 2011: 179456, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22084746

RESUMO

Synchronous renal cell carcinoma in patients with colorectal carcinoma is reported in various percentages ranging from 0.03 up to 4.85% (Halak et al. (2000), Capra et al. (2003)). When surgical treatment is indicated usually two separate operations are planned for resection. In open surgery, in such cases simultaneous resection is recommended if possible. Few reports have described the resection of colorectal and renal cell carcinoma in a single laparoscopic procedure. We have shown that combining left radical nephrectomy and right hemicolectomy is technically feasible, safe and that overall operative time can be limited. In our case operative time was 210 minutes, blood loss 100 milliliters, and duration of hospital stay was 8 days. Adequate port placement, preoperative scheduling, and surgical experience are essential to achieve this goal.

4.
Case Rep Urol ; 2011: 284505, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22606609

RESUMO

We describe an 80-year-old female with a left ureteroileal fistula and simultaneously a right ureteroiliac fistula. Her history highlights the predisposing factors of radiation, major surgery in the region, and presence of bilateral double-J-stents. She was successfully treated with an endovascular approach after being initially misdiagnosed. There seems to be an increase in reporting ureteral fistulas, however this entity remains a rare clinical condition that can lead to life-threatening situations. A fast and accurate diagnosis of an ureteroarterial fistula remains a challenge.

5.
Spinal Cord ; 43(7): 397-9, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15741978

RESUMO

OBJECTIVES: To review the side effects of local injections of botulinum A toxin (BTX-A). METHODS: A medline search for publications about adverse events after injection of BTX-A for lower urinary tract dysfunctions. RESULTS: We found four publications that report generalised side effects after BTX-A injection for detrusor overactivity (two) and detrusor-sphincter dyssynergia (two). The causes of generalised adverse events are not clear, but spread outside the target organ and into the systemic circulation may contribute. The dose used, the injection volume and the injection technique can all play a role. CONCLUSION: Generalised side effects after BTX-A injection for voiding disorders are rare but they can be very disabling for spinal cord-injured patients. Although no long-term side effects are reported so far, urologists should be aware that these effects of BTX-A injections are unknown.


Assuntos
Toxinas Botulínicas Tipo A/efeitos adversos , Toxinas Botulínicas Tipo A/uso terapêutico , Paresia/induzido quimicamente , Paresia/diagnóstico , Bexiga Urinaria Neurogênica/tratamento farmacológico , Transtornos Urinários/tratamento farmacológico , Toxinas Botulínicas Tipo A/administração & dosagem , Humanos , Injeções , Fármacos Neuromusculares/administração & dosagem , Fármacos Neuromusculares/efeitos adversos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA